Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes. This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this effort!
All content for Thrombosis Awareness Library is the property of EEMEA and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes. This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this effort!
This episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.
APS is a systemic autoimmune disease characterized by recurrent thrombotic events in arteries, veins, or small vessels and/or spontaneous early miscarriages with maternal morbidity, caused by persistent antiphospholipid antibodies (aPL).
The precise mechanisms by which aPLs lead to thrombosis are not fully understood. It is believed that these antibodies interfere with the normal function of phospholipids in the blood, essential for coagulation, leading to an increased risk of blood clot formation.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes. This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this effort!
This episode includes AI-generated content.
Thrombosis Awareness Library
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes. This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this effort!
